Discover open access scientific publications

Search, annotate, share and cite publications

Publications by JANA MARKOVÁ

Estimation of Molecular Upper Remission Limit for Monitoring Minimal Residual Disease in Peripheral Blood of Acute Myeloid Leukemia Patients by WT1 Expression

Experimental and Therapeutic Medicine

English

Related publications

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

English

Monitoring of Minimal Residual Disease in Adult Acute Myeloid Leukemia Using Peripheral Blood as an Alternative Source to Bone Marrow

Haematologica

Hematology

2007

English

Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients With Acute Myeloid Leukemia

Klinicheskaya Onkogematologiya/Clinical Oncohematology

Oncology

Hematology

2018

English

Prognostic Value of Prior Consolidation in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation in Minimal Residual Disease-Negative First Complete Remission

American Journal of Hematology

Hematology

2018

English

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

Journal of Clinical Medicine

2017

English

FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Plasma-Derived Exosomes in Acute Myeloid Leukemia for Detection of Minimal Residual Disease: Are We Ready?

Expert Review of Molecular Diagnostics

English

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.

Mediterranean Journal of Hematology and Infectious Diseases

Infectious Diseases

Hematology

2016

English

Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by JANA MARKOVÁ

Estimation of Molecular Upper Remission Limit for Monitoring Minimal Residual Disease in Peripheral Blood of Acute Myeloid Leukemia Patients by WT1 Expression

Related publications

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Monitoring of Minimal Residual Disease in Adult Acute Myeloid Leukemia Using Peripheral Blood as an Alternative Source to Bone Marrow

Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients With Acute Myeloid Leukemia

Prognostic Value of Prior Consolidation in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation in Minimal Residual Disease-Negative First Complete Remission

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease

Plasma-Derived Exosomes in Acute Myeloid Leukemia for Detection of Minimal Residual Disease: Are We Ready?

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.

Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations